申请人:UNIVERSITY OF NOTRE DAME DU LAC
公开号:US11014891B2
公开(公告)日:2021-05-25
A compound is provided, comprising: an Fe(III)-binding or an Fe(III)-bound siderophore; one or more optional linker covalently bound to the siderophore; a drug; and an Fe(III) to Fe(II) reduction triggered linker bound to the drug and the linker or, if no linker is present, then bound to the drug and the siderophore. Compositions and methods including the compound are also provided.
提供了一种化合物,它包括:与 Fe(III)结合或与 Fe(III)结合的苷元;与苷元共价结合的一个或多个任选连接体;药物;以及与药物和连接体结合的 Fe(III)至 Fe(II)还原触发连接体,或者,如果不存在连接体,则与药物和苷元结合。还提供了包括该化合物的组合物和方法。